Morris Charles Q

CIK 00014899665 companiesWILMINGTON, DE

SEC Profile

Transactions

Companies

Filings

CIK

0001489966

Recent Transactions

38 trades

Award
LAVA Therapeutics NV
Share Options (Right to Buy)
2025-02-13+130,850→ 130,850 total
Sale
Radius Health, Inc.
Common Stock
2020-02-26$17.93/sh−1,256→ 33,744 total
Award
Radius Health, Inc.
Stock Option (Right to Buy)
2020-02-20+30,000→ 30,000 total
Award
Radius Health, Inc.
Common Stock
2020-02-20+20,000→ 35,000 total
Award
Radius Health, Inc.
Common Stock
2019-02-22+15,000→ 15,000 total
Award
Radius Health, Inc.
Stock Option (Right to Buy)
2019-02-22+55,000→ 55,000 total
Award
Radius Health, Inc.
Stock Option (Right to Buy)
2018-09-04+130,000→ 130,000 total
Award
ImmunoGen, Inc.
Stock option (right to buy)
2016-07-18$3.05/sh+110,000→ 110,000 total
Sale
ImmunoGen, Inc.
Common Stock
2015-11-27$14.00/sh−5,170→ 27,090 total
Award
ImmunoGen, Inc.
Stock option (right to buy)
2015-07-13$16.72/sh+110,000→ 110,000 total
Sale
ImmunoGen, Inc.
Common Stock
2014-11-28$10.40/sh−5,240→ 32,260 total
Award
ImmunoGen, Inc.
Stock option (right to buy)
2014-07-17$10.79/sh+110,000→ 110,000 total
Exercise/Conversion
ImmunoGen, Inc.
Common Stock
2014-02-26$11.93/sh+6,936→ 44,436 total
Sale
ImmunoGen, Inc.
Common Stock
2014-02-26$17.35/sh−6,936→ 37,500 total
Exercise/Conversion
ImmunoGen, Inc.
Stock Option (right to buy)
2014-02-26$11.93/sh−6,936→ 172,254 total
Exercise/Conversion
ImmunoGen, Inc.
Common Stock
2014-02-20$11.93/sh+13,672→ 51,172 total
Exercise/Conversion
ImmunoGen, Inc.
Stock Option (right to buy)
2014-02-20$11.93/sh−13,672→ 179,190 total
Sale
ImmunoGen, Inc.
Common Stock
2014-02-20$17.10/sh−13,672→ 37,500 total
Exercise/Conversion
ImmunoGen, Inc.
Common Stock
2014-01-22$11.93/sh+1,603→ 39,103 total
Sale
ImmunoGen, Inc.
Common Stock
2014-01-22$17.00/sh−1,603→ 37,500 total
Exercise/Conversion
ImmunoGen, Inc.
Stock Option (right to buy)
2014-01-22$11.93/sh−1,603→ 192,862 total
Exercise/Conversion
ImmunoGen, Inc.
Common Stock
2014-01-21$11.93/sh+5,535→ 43,035 total
Sale
ImmunoGen, Inc.
Common Stock
2014-01-21$17.00/sh−5,535→ 37,500 total
Exercise/Conversion
ImmunoGen, Inc.
Stock Option (right to buy)
2014-01-21$11.93/sh−5,535→ 194,465 total
Sale
ImmunoGen, Inc.
Common Stock
2013-11-26$13.75/sh−12,500→ 37,500 total
Award
ImmunoGen, Inc.
Stock option (right to buy)
2013-07-16$19.02/sh+58,333→ 58,333 total
Disposition from Tender
ALLOS THERAPEUTICS INC
Common Stock
2012-09-04$1.82/sh−655,031→ 0 total
Sale
ALLOS THERAPEUTICS INC
Common Stock
2012-04-27$1.81/sh−7,970→ 655,031 total
Sale
ALLOS THERAPEUTICS INC
Common Stock
2012-04-27$1.81/sh−7,970→ 665,323 total
Sale
ALLOS THERAPEUTICS INC
Common Stock
2012-03-01$1.48/sh−10,292→ 663,001 total
Sale
ALLOS THERAPEUTICS INC
Common Stock
2012-02-29$1.52/sh−10,155→ 673,293 total
Sale
ALLOS THERAPEUTICS INC
Common Stock
2012-02-29$1.52/sh−10,155→ 673,293 total
Award
ALLOS THERAPEUTICS INC
Common Stock
2012-02-28+241,848→ 683,448 total
Award
ALLOS THERAPEUTICS INC
Common Stock
2012-02-28+241,848→ 683,448 total
Sale
ALLOS THERAPEUTICS INC
Common Stock
2011-11-15$1.44/sh−17,829→ 441,600 total
Sale
ALLOS THERAPEUTICS INC
Common Stock
2011-04-27$2.84/sh−9,800→ 459,429 total
Award
ALLOS THERAPEUTICS INC
Common Stock
2011-02-28+185,851→ 469,229 total
Award
ALLOS THERAPEUTICS INC
Common Stock
2010-10-20+173,378→ 283,378 total

Companies

Recent Filings

Address

C/O PRELUDE THERAPEUTICS INCORPORATED 175 INNOVATION BOULEVARD

WILMINGTON, DE, 19805

View on SEC.gov